NEPHROLOGY

 
Within the past five years, nearly 30% of initiated or ongoing studies at Biorasi were those involving CKD subject populations. Biorasi has the experience to deliver Clinical Research Optimized™ in Nephrology clinical trials.

Nephrology Trial Experts

Biorasi has spent over a decade familiarized itself with the nephrology clinical environment and developing the necessary training programs and practices to work seamlessly within that setting, and to reduce variability in the trials we conduct. Identifying and recruiting nephrology clinical trial participants can be frustrating – especially when your trial requires using dialysis-dependent populations. With many dialysis centers running on incredibly tight schedules, and with staff that’s already overworked, finding the right investigators and other facilitators can quickly become a barrier to success in any nephrology trial. Every therapeutic area has unique issues, but with nephrology trials the difficulty can be much higher than in other specializations.

Deep Understanding of Nephrology and the CKD Population 

Biorasi has a long history of running successful trials in the chronic kidney disease space, and we’ve used that time to become true experts in nephrology clinical research. We’ve forged partnerships and connections with some of the top independent sites and site/LDO networks both within the United States, and abroad. We’ve built deep and lasting relationships with respected investigators. Our staff has trained extensively on managing and monitoring these uniquely challenging trials. In short, we are well set up to deliver Clinical Research Optimized™ in your nephrology trial.

"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."

VP of Global Clinical Development, Top Specialty Pharma
 

Latest News and Blogs

Why Aren’t There Any FDA-Approved Drugs to Treat NASH?

The liver does many important things in the body, such as filtering of the blood and metabolizing all compounds, including food and drugs, that enter the body. In that vein, liver disease can be absolutely devastating.   Non-alcoholic fatty liver disease (NAFLD)...

10 Lessons On Success in Asia-PAC Trials from DIA 2018

Earlier this year, a few of us attended DIA 2018 to represent Biorasi. While there, we were fortunate enough to be able to give a talk about some of our experiences entitled “Balancing Unity and Individuality: Leadership Skills for Managing Culturally Divergent...

Contact Biorasi

1 + 3 =